ArticleProceedings of the National Academy of Sciences of the United States of America2025

TRIM24 as a therapeutic target in endocrine treatment-resistant breast cancer.

Nuno Padrão et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.